Review
doi: 10.1089/dia.2017.2505.
New Insulins, Biosimilars, and Insulin Therapy
Affiliations
- PMID: 28192016
- DOI: 10.1089/dia.2017.2505
Item in Clipboard
Review
New Insulins, Biosimilars, and Insulin Therapy
Diabetes Technol Ther.
2017 Feb.
Free article
No abstract available
Similar articles
-
Role of Devices in Insulin Delivery.Diabetes Technol Ther. 2017 Feb;19(2):76-78. doi: 10.1089/dia.2017.0011. Diabetes Technol Ther. 2017. PMID: 28118052 No abstract available.
-
Novel and Emerging Insulin Preparations for Type 2 Diabetes.Can J Diabetes. 2015 Dec;39 Suppl 5:S160-6. doi: 10.1016/j.jcjd.2015.09.082. Can J Diabetes. 2015. PMID: 26653255 No abstract available.
-
New Medications for the Treatment of Diabetes.Diabetes Technol Ther. 2017 Feb;19(S1):S128-S140. doi: 10.1089/dia.2017.2512. Diabetes Technol Ther. 2017. PMID: 28192022 Review. No abstract available.
-
New Insulins, Biosimilars, and Insulin Therapy.Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505. Diabetes Technol Ther. 2018. PMID: 29437477 Review. No abstract available.
-
Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.Can J Diabetes. 2015 Dec;39 Suppl 5:S176-82. doi: 10.1016/j.jcjd.2015.09.083. Can J Diabetes. 2015. PMID: 26654861 No abstract available.
Cited by
-
An Empirical Analysis of the Perceived Challenges and Benefits of Introducing Biosimilars in Bangladesh: A Paradigm Shift.Biomolecules. 2018 Sep 5;8(3):89. doi: 10.3390/biom8030089. Biomolecules. 2018. PMID: 30189610 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
